Petros Pharmaceuticals Inc (PTPI) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.01x

Petros Pharmaceuticals Inc (PTPI) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting $10.90K (capex $5.45K plus investments $-5.45K) from operating cash flow of $965.40K. See Petros Pharmaceuticals Inc (PTPI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$10.90K
Capex + Investments

Operating Cash Flow

$965.40K
USD

Capital Expenditures

$5.45K
USD

Petros Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2019)

Historical reinvestment intensity for Petros Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see Petros Pharmaceuticals Inc cash conversion from operations.

Annual Cash Flow Reinvestment Rate for Petros Pharmaceuticals Inc (2018–2019)

Year-by-year capital reinvestment analysis for Petros Pharmaceuticals Inc. See Petros Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.06x $143.08K $2.53 Million $71.54K ▼ -75.8%
2018 0.23x $1.88 Million $8.02 Million $1.88 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow